Evidence map›Paper›PMID 32071209›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2020

The role of critical micellization concentration in efficacy and toxicity of supramolecular polymers.

Hao Su, Feihu Wang, Wei Ran, Weijie Zhang, Wenbing Dai, Han Wang, Caleb F Anderson, Zongyuan Wang, Chao Zheng, Pengcheng Zhang and 2 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
4.7field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 105 citations in OpenAlex.

  1. Therapeutic peptides and proteins: Status and developments in drug delivery.Journal of controlled release : official journal of the Controlled Release Society · 2026
    Review
  2. Review
  3. Review
  4. Precise Regulation of Membrane Proteins: From Physical Technology to Biomolecular Strategy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Review
  5. RapidActa pharmaceutica Sinica. B · 2026
    Article
  6. Review
  7. Review
  8. Pressure-Induced Ultralow Critical Micelle Concentration of Surfactant for Encapsulating Dye.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Discovery, validation, and prodrug design of an ACE2 activator for treating bacterial infection-induced lung inflammation.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Hao SuDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Feihu WangDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Wei RanState Key Laboratory of Drug Research and Center for Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Weijie ZhangDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Wenbing DaiDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Han WangDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Caleb F AndersonDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Zongyuan WangDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218.
Chao ZhengState Key Laboratory of Drug Research and Center for Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Pengcheng ZhangState Key Laboratory of Drug Research and Center for Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Yaping LiState Key Laboratory of Drug Research and Center for Pharmaceutics, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China.
Honggang CuiDepartment of Chemical and Biomolecular Engineering, The Johns Hopkins University, Baltimore, MD 21218; hcui6@jhu.edu.ORCID 0000-0002-4684-2655
Johns Hopkins University · USChinese Academy of Sciences · CN

Funding

T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer ResearchT32CA153952 · NCI · JOHNS HOPKINS UNIVERSITY · PI Denis Wirtz · 2015 to 2026
$3.5M
T-32 NIH Postdoctoral Training Program in Nanotechnology for Cancer Medicine NTCMT32CA130840 · NCI · JOHNS HOPKINS UNIVERSITY · PI WIRTZ, DENIS · 2008 to 2012
$1.2M
NCI NIH HHS T32 CA130840NCI NIH HHS T32 CA153952
6 · The paper itself

Abstract

The inception and development of supramolecular chemistry have provided a vast library of supramolecular structures and materials for improved practice of medicine. In the context of therapeutic delivery, while supramolecular nanostructures offer a wide variety of morphologies as drug carriers for optimized targeting and controlled release, concerns are often raised as to how their morphological stability and structural integrity impact their in vivo performance. After intravenous (i.v.) administration, the intrinsic reversible and dynamic feature of supramolecular assemblies may lead them to dissociate upon plasma dilution to a concentration below their critical micellization concentration (CMC). As such, CMC represents an important characteristic for supramolecular biomaterials design, but its pharmaceutical role remains elusive. Here, we report the design of a series of self-assembling prodrugs (SAPDs) that spontaneously associate in aqueous solution into supramolecular polymers (SPs) with varying CMCs. Two hydrophobic camptothecin (CPT) molecules were conjugated onto oligoethylene-glycol (OEG)-decorated segments with various OEG repeat numbers (2, 4, 6, 8). Our studies show that the lower the CMC, the lower the maximum tolerated dose (MTD) in rodents. When administrated at the same dosage of 10 mg/kg (CPT equivalent), SAPD 1, the one with the lowest CMC, shows the best efficacy in tumor suppression. These observations can be explained by the circulation and dissociation of SAPD SPs and the difference in molecular and supramolecular distribution between excretion and organ uptake. We believe these findings offer important insight into the role of supramolecular stability in determining their therapeutic index and in vivo efficacy.

Indexed as

MicellesAnimalsAntineoplastic AgentsCamptothecinDrug CarriersFemaleHT29 CellsHumansMaximum Tolerated DoseMiceMice, NudePolyethylene GlycolsPolymerizationProdrugsRatsRats, Sprague-DawleyAntineoplastic AgentsCamptothecinDrug CarriersMicellesPolyethylene GlycolsProdrugscritical micellization concentrationdrug deliverymolecular assemblyprodrugssupramolecular polymers

Identifiers

PMID32071209
PMCPMC7060728
OpenAlexW3006733958

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.